Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Shortages and supply disruptions (16)
- Safety monitoring and information (127)
- Compliance and enforcement (33)
- Import and export (31)
- Sunscreens (9)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Cosmetics (1)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
798 result(s) found, displaying 626 to 650
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alertsPrecautionary product notification for GlaxoSmithKline Australia (GSK) influenza vaccine, Fluarix
-
-
Safety alerts
-
Safety alertsAbout seasonal flu vaccine: 2013 seasonal influenza vaccines for use in children
-
Safety alerts
-
-
Safety alertsThe TGA has performed and reported on a large number of tests on the chemical properties, physical properties and the biological safety of the gels and shells of PIP breast implants.
-
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Market actionsGlaxoSmithKline (GSK) and Alphapharm, in consultation with the TGA, are undertaking a voluntary recall of several batches of Ventolin and Asmol inhalers due to a fault in the delivery mechanism of a small number of inhalers within each batch. This can lead to less than the full dose being delivered for each puff.
-
Safety alerts
-
-
-
Safety alerts
-
-
Market actionsWe are recalling all batches of Muscletech Hydroxystim capsules due to the presence of the banned substance DMAA. Consult your doctor if you have concerns.